U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07681674) titled 'Bicycle Continued Access Protocol (BiCAP) for Participants Receiving a Bicycle Investigational Product' on June 26.
Brief Summary: BiCAP-201 trial offers continued access to Bicycle investigational product treatments zelenectide pevedotin, nuzefatide pevedotin, and BT7480 for participants currently receiving and deriving clinical benefit from one of these treatments in a Bicycle Therapeutics-sponsored clinical trial. Bicycle Therapeutics will continue to monitor longer term safety of these treatments.
Study Start Date: Aug. 01
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Tumors
Intervention:
DRUG: Zelenectide pevedotin...